When investigating susceptibility testing methods for polymyxins, 24 multidrug resistant clinical 2 isolates of Pseudomonas aerugionsa were observed to have a distinct, reproducible phenotype in 3 which skipped wells were observed during microbroth dilution testing for polymyxin B. Possible 4 mechanisms underlying this phenotype were investigated. The effects of varying concentrations 5 of polymyxin B on growth, on expression of resistance genes and on outer membrane 6 permeability were observed. Real time PCR was performed to compare the expression, in 7 response to selected concentrations of polymyxin B, of genes related to the PhoP-PhoQ and 8
INTRODUCTION 3
The emergence of multidrug resistant Gram-negative organisms and the simultaneous 4 lack of new clinically-available antimicrobial agents have lead to a resurgence of older 5 compounds such as the polymyxins (6). These agents, including polymyxin B and colistin, have 6 highly potent activity against Gram-negative organisms including Pseudomonas aeruginosa, but 7 were previously abandoned due to a reported high incidence of nephrotoxicity and neurotoxicity 8 (12). 9
Resistance to polymyxin B is predominantly associated with decreased uptake into the 10 bacterial cell resulting from a reduced capacity for initial binding (23) . Polymyxin B and other 11 polycationic compounds enter the cell via a process known as self promoted uptake (10, 11) . 12 Polymyxin B binds to outer membrane lipopolysaccharide (LPS) displacing Mg 2+ and disrupting 13 the Mg 2+ cross bridges between anionic LPS molecules in the outer membrane, thus leading to 14 membrane destabilization. This leads to an increased permeability of the outer membrane 15 allowing further uptake of the antibiotic. In P. aeruginosa the ability of polymyxin to 16 permeabilize outer membranes reflects its ability to bind to LPS with higher affinity than the 17 from individual MIC plates in triplicate on separate days and qPCR was performed on each 6 repeat in at least duplicate. 7 8 Polymyxin B outer membrane interaction studies. 9
The hydrophobic fluorescent probe 1-N-phenylnaphthylamine (NPN) was used as described by 10 Loh et al. to study the interaction of polymyxin B with the outer membranes of clinical isolates 11 compared to PAO1 (13). Overnight cultures grown at 37ºC in CAMHB containing either 0, 12 0.125 or 2 µg/ml polymyxin B were diluted 1:100 in fresh CAMHB containing the the respective 13 polymyxin B concentrations. Fifty ml samples of mid-log phase cells were harvested by 14 centrifugation at 3,000 x g for 10 min, washed once with and resuspended in 5 mM sodium 15 HEPES buffer (pH 7.2), with 5 µM carbonyl cyanide m-chlorophenylhydrazone (an uncoupler), 16 at an optical density at 600 nm of 0.5. Fluorescence was measured at an excitation wavelength of 17 350 nm and an emission wavelength of 420 nm using a Perkin Elmer LS 50B fluorescent 18 spectrophotometer. NPN was added to a final concentration of 10 µM to obtain baseline 19 fluorescence. Polymyxin B was added to final concentrations of 0. 25, 0.5, 1, 2, 4, 8, 16, 32 and 20 64 µg/ml. 21
22
Sequencing of pmrAB and pmr promoter region including PA4773. 23 on July 7, 2017 by guest http://aac.asm.org/ Downloaded from upstream region of PA4773 as well as PA4773 itself (1,069 bp), and a second set of primers was 5 designed to amplify the region flanking pmrAB (2,349 bp). The OprH-PhoPQ operon was 6 amplified as three overlapping PCR fragments for coverage of all three genes as well as the 7 upstream non-coding region. Sequencing was performed using Applied Biosystems BigDye v3.1 8
Terminator Chemistry and run on an Applied Biosystems PRISM 377 automated sequencer. 9 10 Genotyping. P. aeurinosa isolates PAO1, 9BR, 19BR and 213BR were typed by pulsed-field gel 11 electrophoresis (PFGE) of SpeI-digested chromosomal DNA. SpeI restriction fragments were 12 separated using the CHEF-DR® III System (Bio-Rad Laboratories, Hercules, CA) and PFGE 13 profiles, then digitized on the Gel Doc 1000 (Bio-Rad Laboratories) with Quantity One® (Bio-14 Rad Laboratories) software, and the results were analyzed using Bionumerics™ version 3.5 15 (Applied Maths, Austin, TX) software. The dendrogram was constructed by the unweighted pair 16 group method with arithmetic averages with the Dice coefficient. 17
18

RESULTS AND CONCLUSIONS 19
Antimicrobial susceptibilities and the skipped well phenomenon. The occurrence of skipped 20 wells during polymyxin B MIC testing was observed for 24 isolates. This did not coincide with 21 the occurrence of skipped wells during colistin MIC testing since only eight of these isolates 22 presented this phenotype. Polymyxin B microbroth dilution assays producing skipped wells were 23 found to be reproducible in only 10-15% of trials from the original stock cultures; however, 1 when samples were harvested from the microtitre plate wells with growth at concentrations 2 higher than the skipped wells, a reproducible skipped well phenotype was observed. This 3 indicates that only a proportion of bacteria in the original stock cultures had the skipped well 4 phenomenom, but that these bred true. Antimicrobial susceptibilities for the selected clinical 5 isolates 9BR, 19BR and 213BR are presented in Table 1 . Isolate 19BR did not grow in 6 concentrations of 0.25 and 0.5 µg/ml polymyxin B and isolate 213BR did not grow in 0.5 and 1 7 µg/ml. To determine the effect of polymyxin B on the growth of these isolates, growth was 8 assessed, in the presence of 0.125 and 2 µg/ml polymyxin B, for skipped well isolates 19BR and 9 213BR compared to a polymyxin B susceptible laboratory wild type strain PAO1 and isolate 10 9BR that was reproducibly polymyxin B resistant without skipped wells (Figure 1 ). The 11 presence of 0.125 µg/ml polymyxin B, a concentration below the liberal MIC of each isolate, had 12 no effect on the growth of any of the four isolates, while the presence of 2 µg/ml polymyxin B 13 extended the lag phase of both skipped well isolates 19BR and 213BR by approximately 6 and 4 14 hours respectively. The extended lag phases observed for skipped well isolates 19BR and 213BR 15 in the presence of 2 µg/ml polymyxin B were consistent with the need for a period of adaptation 16 to permit growth at higher concentrations of polymyxin B. polymyxin B, the expression levels of all three genes of interest were comparable to the 6 expression levels observed in PAO1. In contrast, the expression levels in the polymyxin B 7 resistant isolate 9BR of arnB and PA4773, but not phoQ were significantly higher (p<0.05) than 8 in PAO1, with 52-to 280-fold increases respectively. While expression was not affected by sub-9 inhibitory (0.125 µg/ml) polymyxin B treatment for any of the studied genes in the susceptible 10 PAO1 strain (data not shown) or the two skipped well isolates, the polymyxin B resistant isolate 11 exhibited a concentration dependent increase in expression of arnB and PA4773. At 2 µg/ml 12 polymyxin B, although the wild type did not grow, at this concentration the skipped well isolates 13 demonstrated a dramatic increase in the expression of phoQ, arnB and PA4773 (pmrAB operon) 14 thus implicating a role for all three of these genes in the skipped well phenomenon. In a study 15 investigating Lipid A modifications in CF, environmental and non-CF isolates of P. aeruginosa, 16
Ernst et al found that aminoarabinose was only present in isolates obtained from CF patients (4). 17
The authors further indicated that at the modification levels found in early CF isolates of P. 18 aeruginosa, this modification alone did not appear to cause significant levels of resistance; 19 however, the modification was always found to be present in colistin resistant CF isolates (4). 20
The high levels of expression of the aminoarabinose modification operon seen in isolate 9BR 21 suggests that this LPS modification is also likely to be present in polymyxin B resistant non-CF 22
isolates. 23 on July 7, 2017 by guest http://aac.asm.org/
Downloaded from
As the regulatory operon PA4773-PA4775-pmrAB-PA4778 as well as its downstream 1 effector operon arnBCADTEF-PA3559 demonstrated increased expression in both the stably 2 resistant isolate, 9BR, as well as in the two skipped well isolates, 19BR and 213BR, in response 3 to polymyxin B, we believed that regulatory mutations in the upstream region of the PA4773-4 PA4775-pmrAB-PA4778 operon may be involved in the polymyxin B resistance observed for all 5 of these isolates. When the non-coding region upstream of the PA4773-PA4775-pmrAB-PA4778 6 operon was amplified and sequenced a large 101 bp deletion and a single base pair change were 7 observed for all three clinical isolates when compared to the wildtype PAO1 strain (Table 2) . To 8 determine if these mutations were unique to these isolates a comparison was also made to other 9 sequenced strains including another wildtype stain, PA14, and the earliest archived cystic 10 fibrosis Liverpool epidemic strain, LESB58 (24). A number of single base pair changes were 11 observed when comparing each of these strains (including the previously sequenced PA14 and 12 LESB58 strains) to PAO1; however, neither the single base pair change, nor the large deletion 13 were observed in any of PAO1, PA14 nor LESB58. Interestingly, LESB58 did have a 101 bp 14 insertion compared to PAO1 and PA14 within the location where the deletion was observed in 15 the Brazilian strains. A study of a second Liverpool epidemic strain, LES431, demonstrated that 16 this isolate exhibited moderate upregulation of pmrA and pmrB (6.7 and 9.2 fold respectively as 17 determined by microarray) compared to PAO1 in LB media (21). The alterations in this promoter 18 site, along with the increased expression of the PA4773-PA4775-pmrAB-PA4778 operon, in both 19 the Brazilian and the LES strains implicate this region in regulation of this operon. The finding 20 that all three clinical isolates from Brazil possessed the identical mutations in this region was 21 surprising, as the isolates exhibited both distinct phenotypes and differing expression patterns; 22 on July 7, 2017 by guest http://aac.asm.org/ Downloaded from however, the PFGE genotyping seen in figure 3 does indicate that these three strains are related 1 with a Dice coefficient of >85% but are not clonal. 2
As previous work found two phenotypically-distinct polymyxin B resistant mutants 3 selected from the wild type PAK strain on LB plates containing 20 to 50 µg/ml polymyxin B 4 each possessed a single mutation (L243Q and A248V) in the histidine box of PmrB near the 5 active site H249 and contained aminoarabinose under non-inducing conditions (18), we also 6 sought to characterize the PmrAB locus of these isolates. In sequencing PA4773, PmrA and 7 PmrB, the three strains under investigation were again identical to one another, with the 8 exception of a single amino acid deletion in 9BR (Table 2) . When compared to PAO1 a missense 9 mutation in PmrA (L71R) was observed, and this mutation was also found in LESB58. The 10 missense mutation Y345H was also observed in the wildtype strain PA14 as well as in LESB58 11 and so is not likely to be involved in polymyxin resistance. No mutations near the previously 12 reported polymyxin B resistance mutations (18) in the histidine box of PmrB were observed. 13
As the major differences in the expression data between the skipped well polymyxin B 14 resistant isolates and the constitutively polymyxin B resistant isolates was found to be in the 15 induced expression of phoQ, we anticipated major differences in the sequence data at this locus; 16 however, no differences between these three isolates were observed (Table 2) . 17
Polymyxin B interaction studies. As modifications to LPS influence the ability of polymyxin B 18
to interact with the outer membrane of P. aeruginosa, NPN assays were performed to compare 19 the ability of polymyxin B to interact with the membranes of the skipped well isolates compared 20 to the polymyxin B susceptible PAO1 strain and the polymyxin B resistant isolate 9BR. NPN is a 21 fluorescent probe that fluoresces weakly in aqueous solution but strongly in non-polar or 22 hydrophobic environments. Under normal conditions, NPN is excluded from the outer membrane 23 due to the tight cross-bridging of LPS by divalent cations, and does not fluoresce. Upon 1 disruption of the outer membrane, NPN partitions into the outer membrane interior and an 2 increase in fluorescence can be observed. The initial rate of increase in fluorescence varies with 3 the concentration of polymyxin B and defines the susceptibility of the outer membrane to 4 permeabilization, which in turn relates to the efficiency of self promoted uptake. As expected, 5 polymyxin B was able to permeabilize the membranes of all isolates tested in a concentration 6 dependent manner (Figure 4) , with the outer membrane of PAO1 being permeabilized at a much 7 lower concentration of 4 µg/ml polymyxin B (data not shown) and to a greater extent at all 8 concentrations tested compared to the outer membrane of 9BR, which was only affected at 9 concentrations ≥32 µg/ml (data not shown). Permeabilization of the outer membrane of the 10 skipped well isolate 19BR fell between the susceptible and the resistant isolate and was observed 11 at polymyxin B concentrations ≥8 µg/ml. 12 Interestingly, pre-incubation with polymyxin B had differing effects on the efficiency of 13 self promoted uptake as well as the background levels of outer membrane permeability of each 14 isolate. Pre-incubation with 0.125 µg/ml of polymyxin B had little to no effect on the 15 background permeability of either the susceptible PAO1 strain (Figure 4 a-c) or on the resistant 16 9BR strain (Figure 1 d-f) , while background levels for 19BR increased significantly. Further 17 increases in background outer membrane permeability were observed after pre-incubation with 2 18 µg/ml polymyxin B for both 9BR and 19BR. With regard to the effect on self promoted uptake, 19 at intermediate concentrations of polymyxin B, as represented by 8 µg/ml polymyxin B in Figure  20 4, pre-incubation of PAO1 with 0.125 µg/ml did retard the initial rate of uptake. Similar results 21 were observed for 19BR at 16 µg/ml as well as for 213BR (data not shown). These data indicate 22 that exposure to sub-inhibitory concentrations of polymyxin B caused significant structural 23 alterations in the outer membranes of the skipped well isolates 19BR and 213BR which affected 1 their ability to interact with polymyxin B, consistent with the dramatic alterations in the 2 expression levels of arnB, which is the first gene of the aminoarabinosylation operon that is 3 known to influence polymyxin self promoted uptake and susceptibility by reducing the negative 4 charge on LPS. While slight to moderate increases in baseline permeability of the outer 5 membrane of 9BR to NPN were observed after pre-incubation with polymyxin B, no differences 6 in the rate of NPN uptake were observed after further addition polymyxin B, thus indicating that, 7 in contrast to the skipped well isolates, pre-exposure of this resistant isolate to polymyxin B had 8 little effect on the ability of the outer membrane to bind additional polymyxin B. 9
Concluding remarks. The data shown here support the notion that clinical isolates of P. 10 aeruginosa have varying abilities to adapt to the presence of polymyxins. While the polymyxin 11 B resistant isolate observed in this study appeared to constitutively over-express the PmrA-PmrB 12 two-component regulatory system and was capable of only moderate adaptation as indicated by a 13 concentration dependent upregulation of the PmrA-PmrB system and by minor changes in 14 baseline NPN permeability upon exposure to polymyxin B, the skipped well isolates surveyed 15 appeared to have a heightened ability to respond to higher concentrations of polymyxin B than to 16 lower concentrations, although of note, the levels of expression of these genes did not reach the 17 same high levels as 9BR. This enhanced adaptability was evidenced by the extended lag phase, 18 by dramatic changes in expression of both the PhoP-PhoQ and the PmrA-PmrB systems, and by 19 apparent structural changes in response to polymyxin B, affecting the permeabilization of outer 20 membranes of these isolates. Of note, the structural changes in the outer membrane of the 21 skipped well isolate, presumed on the basis the NPN results, occurred in a concentration 22 dependent manner in response to pre-incubation with 0.125 µg/ml and 2 µg/ml polymyxin B, 23 while the expression of arnB, phoQ and PA4773 only appeared to be increased upon exposure to 1 2 µg/ml polymyxin B. This discordance between the two assays may indicate the involvement of 2 other systems affecting membrane permeability in response to low concentrations of polymyxin 3 B in the skipped well isolates. A number of mutations were observed in the regulatory regions 4 controlling pmrAB and phoPQ as well as in these genes themselves when the isolates were 5 compared to wildtype isolates; however, only a single amino acid deletion in PmrB was observed 6 in the constitutively resistant isolate compared to the skipped well isolates. The contributions of 7 these mutations to the observed phenotypes have yet to be determined. The organisms displaying 8 the skipped well phenomenon appear to have the heightened ability to sense specific polymyxin 9 B concentrations and induce the PhoP-PhoQ and PmrA-PmrB systems resulting in polymyxin 10 resistance and the skipped well phenotype. Thus the ability of these organisms to grow at 11 specific concentrations above those of the skipped wells relies on the differential effects of 12 inhibition by particular polymyxin concentrations and the speed of induction of these operons. 13
Most importantly, these data are the first to associate the PhoP-PhoQ, PmrA-PmrB systems and 14 the LPS modification operon with polymyxin-inducible polymyxin B resistance in non-CF 15 clinical isolates. 16 
